![Windtree Therapeutics Com](/common/images/company/N_DSCO.png)
Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT) Corporate Rebranding Initiative Reflects New Direction for Company PR Newswire WARRINGTON, Pa., April 18, 2016...
Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business Updates Company Remains on Track to Deliver Key AEROSURF® Phase 2 Program Milestones PR Newswire WARRINGTON...
Discovery Labs to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Thursday, March 24, 2016 PR Newswire WARRINGTON, Pa., March 16, 2016 WARRINGTON, Pa., March 16, 2016...
Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire WARRINGTON, Pa., Feb. 3, 2016 WARRINGTON, Pa., Feb. 3, 2016 /PRNewswire/ -- Discovery Laboratories, Inc...
Discovery Labs Announces Appointment of New Chief Executive Officer and Provides an Update on AEROSURF® Phase 2 Program PR Newswire WARRINGTON, Pa., Feb. 1, 2016 WARRINGTON, Pa., Feb. 1, 2016...
Discovery Labs Announces Reverse Stock Split PR Newswire WARRINGTON, Pa., Jan. 21, 2016 WARRINGTON, Pa., Jan. 21, 2016 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) today...
Discovery Labs Announces Initiation of AEROSURF® Phase 2b Clinical Trial PR Newswire WARRINGTON, Pa., Dec. 29, 2015 WARRINGTON, Pa., Dec. 29, 2015 /PRNewswire/ -- Discovery Laboratories, Inc...
Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot Topics in Neonatology Annual Meeting PR Newswire WARRINGTON, Pa., Dec...
Discovery Labs Announces Top Line Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Encouraging phase 2a data suggest that aerosolized KL4...
Discovery Labs to Announce Results from AEROSURF® Phase 2a Expansion Clinical Trial Conference Call Scheduled for Thursday, November 12, 2015 at 8:00 a.m. Eastern Time PR Newswire WARRINGTON...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.